Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

The Cholera Epidemics in Hamburg and What to Learn for COVID-19 (SARS-CoV-2).

Tárnok A.

Cytometry A. 2020 Mar 18. doi: 10.1002/cyto.a.23999. [Epub ahead of print]

PMID:
32187818
2.
3.

The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.

Li YC, Bai WZ, Hashikawa T.

J Med Virol. 2020 Feb 27. doi: 10.1002/jmv.25728. [Epub ahead of print] Review.

PMID:
32104915
4.

Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.

Gurwitz D.

Drug Dev Res. 2020 Mar 4. doi: 10.1002/ddr.21656. [Epub ahead of print]

PMID:
32129518
5.

[Analysis on the epidemic factors for the Corona Virus Disease].

Yang HY, Duan GC.

Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Mar 3;54(0):E021. doi: 10.3760/cma.j.cn112150-20200227-00196. [Epub ahead of print] Chinese.

PMID:
32125129
6.

Perinatal Transmission of COVID-19 Associated SARS-CoV-2: Should We Worry?

Fan C, Lei D, Fang C, Li C, Wang M, Liu Y, Bao Y, Sun Y, Huang J, Guo Y, Yu Y, Wang S.

Clin Infect Dis. 2020 Mar 17. pii: ciaa226. doi: 10.1093/cid/ciaa226. [Epub ahead of print]

PMID:
32182347
7.

Coronavirus Disease 2019: Coronaviruses and Blood Safety.

Chang L, Yan Y, Wang L.

Transfus Med Rev. 2020 Feb 21. pii: S0887-7963(20)30014-6. doi: 10.1016/j.tmrv.2020.02.003. [Epub ahead of print] Review.

PMID:
32107119
8.

First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA.

Ghinai I, McPherson TD, Hunter JC, Kirking HL, Christiansen D, Joshi K, Rubin R, Morales-Estrada S, Black SR, Pacilli M, Fricchione MJ, Chugh RK, Walblay KA, Ahmed NS, Stoecker WC, Hasan NF, Burdsall DP, Reese HE, Wallace M, Wang C, Moeller D, Korpics J, Novosad SA, Benowitz I, Jacobs MW, Dasari VS, Patel MT, Kauerauf J, Charles EM, Ezike NO, Chu V, Midgley CM, Rolfes MA, Gerber SI, Lu X, Lindstrom S, Verani JR, Layden JE; Illinois COVID-19 Investigation Team.

Lancet. 2020 Mar 13. pii: S0140-6736(20)30607-3. doi: 10.1016/S0140-6736(20)30607-3. [Epub ahead of print]

PMID:
32178768
9.

The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options.

Khan S, Siddique R, Shereen MA, Ali A, Liu J, Bai Q, Bashir N, Xue M.

J Clin Microbiol. 2020 Mar 11. pii: JCM.00187-20. doi: 10.1128/JCM.00187-20. [Epub ahead of print] Review.

PMID:
32161092
10.

Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.

Lai CC, Liu YH, Wang CY, Wang YH, Hsueh SC, Yen MY, Ko WC, Hsueh PR.

J Microbiol Immunol Infect. 2020 Mar 4. pii: S1684-1182(20)30040-2. doi: 10.1016/j.jmii.2020.02.012. [Epub ahead of print] Review.

11.

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.

Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD.

Allergy. 2020 Feb 19. doi: 10.1111/all.14238. [Epub ahead of print]

PMID:
32077115
12.

Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.

Liu Z, Xiao X, Wei X, Li J, Yang J, Tan H, Zhu J, Zhang Q, Wu J, Liu L.

J Med Virol. 2020 Feb 26. doi: 10.1002/jmv.25726. [Epub ahead of print]

PMID:
32100877
13.

SARS-CoV-2, the Virus that Causes COVID-19: Cytometry and the New Challenge for Global Health.

Cossarizza A, De Biasi S, Guaraldi G, Girardis M, Mussini C; Modena Covid-19 Working Group (MoCo19)#.

Cytometry A. 2020 Mar 18. doi: 10.1002/cyto.a.24002. [Epub ahead of print] No abstract available.

PMID:
32187834
14.

Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19.

Patel R, Babady E, Theel ES, Storch GA, Pinsky BA, St George K, Smith TC, Bertuzzi S.

mBio. 2020 Mar 26;11(2). pii: e00722-20. doi: 10.1128/mBio.00722-20. No abstract available.

15.

From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.

Kandeel M, Ibrahim A, Fayez M, Al-Nazawi M.

J Med Virol. 2020 Mar 11. doi: 10.1002/jmv.25754. [Epub ahead of print]

PMID:
32159237
16.

The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?

Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, Baghbanzadeh M, Aghamohammadi N, Zhang W, Haque U.

Int J Epidemiol. 2020 Feb 22. pii: dyaa033. doi: 10.1093/ije/dyaa033. [Epub ahead of print]

PMID:
32086938
17.

Compounds with therapeutic potential against novel respiratory 2019 coronavirus.

Martinez MA.

Antimicrob Agents Chemother. 2020 Mar 9. pii: AAC.00399-20. doi: 10.1128/AAC.00399-20. [Epub ahead of print] Review.

PMID:
32152082
18.

Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.

Li X, Zai J, Zhao Q, Nie Q, Li Y, Foley BT, Chaillon A.

J Med Virol. 2020 Feb 27. doi: 10.1002/jmv.25731. [Epub ahead of print]

PMID:
32104911
19.

A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2.

Grifoni A, Sidney J, Zhang Y, Scheuermann RH, Peters B, Sette A.

Cell Host Microbe. 2020 Mar 12. pii: S1931-3128(20)30166-9. doi: 10.1016/j.chom.2020.03.002. [Epub ahead of print]

20.

Coronavirus disease (COVID-19) and neonate: What neonatologist need to know.

Lu Q, Shi Y.

J Med Virol. 2020 Mar 1. doi: 10.1002/jmv.25740. [Epub ahead of print] Review.

PMID:
32115733

Supplemental Content

Support Center